- Molecular NamePargyline
- SynonymBenzyl-methyl-2-propinylamin; Methylbenzylpropynylamine; Methylbenzylpropynylamine hydrochloride; N-Benzyl-N-methyl-2-propyn-1-amine; N-Benzyl-N-methyl-2-propynylamine; N-Benzyl-N-methyl-2-propynylamine hydrochloride; N-Methyl-N-2-propynylbenzylamine; Paragyline; Pargylamine; Pargylin; Pargyline chloride; Pargyline hydrochloride
- Weight159.232
- Drugbank_IDDB01626
- ACS_NO555-57-7
- Show 3D model
- LogP (experiment)N/A
- LogP (predicted, AB/LogP v2.0)2.15
- pkaN/A
- LogD (pH=7, predicted)2.03
- Solubility (experiment)N/A
- LogS (predicted, ACD/Labs)(ph=7)-1.76
- LogSw (predicted, AB/LogsW2.0)8.9
- Sw (mg/ml) (predicted, ACD/Labs)2.1
- No.of HBond Donors0
- No.of HBond Acceptors1
- No.of Rotatable Bonds4
- TPSA3.24
- StatusFDA approved
- AdministrationN/A
- PharmacologyA monoamine oxidase B (MAO-B) inhibitor.
- Absorption_valueN/A
- Absorption (description)N/A
- Caco_2N/A
- BioavailabilityN/A
- Protein bindingN/A
- Volume of distribution (VD)N/A
- Blood/Plasma Partitioning ratio (D_blood)N/A
- MetabollsmN/A
- Half lifeN/A
- ExcretionN/A
- Urinary ExcretionN/A
- CleranceN/A
- ToxicityN/A
- LD50 (rat)LD50=300
- LD50 (mouse)LD50=680